Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock (XOMAO)
XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
XNAS:XOMAO
25.47
0.51%

Ask
$25.89 - 1.00
Bid
$25.00 - 210.00
Low
$25.47
High
$25.48
Open
$25.48
Prev Close
$25.34
52W High
25.76
52W Low
23.32
Volume
317
Avg Vol (3m)
2022.7
Float

Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 389
0
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2834
Sector: Health Technology
Industry: Pharmaceuticals: Major
Date Listed: 04/12/2021
Primary Exchange: XNAS

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Phone: 510-204-7239
Address: 2200 Powell Street
Address 2: Suite 310
City: Emeryville
State: CA
Postal Code: 94608
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
13
P/E (TTM)
P/B (TTM)
EPS
0.7
Round Lot
100
Share Class Shares Outstanding
1.60M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own XOMAO. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.